Enovis CORP EV/EBIT ENOV
Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2012.
- Today, Oct 23, 2026
- 191×
- 10-year median
- 20.2×
- Against its 10-year history
- 98th
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 13.2× to 216×
- Peer median
- 25.5×
Enovis CORP's EV/EBIT is 191× as of Oct 23, 2026.
That is above its ten-year median of 20.2×, higher than on 98% of days in the last ten years.
Over that time it ranged from 13.2× in Oct 2016 to 216× in Aug 2026.
The median for 10 medical instruments and supplies stocks of a similar size is 25.5×.
EV/EBIT over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 191× | 176× | 216× |
| 2025 | n/m a value too high to mean anything | ||
| 2024 | n/m a value too high to mean anything | ||
| 2023 | n/m a value too high to mean anything | ||
| 2022 | 50.3× | 49.4× | 67.9× |
| 2021 | 69.2× | 24.1× | 76.9× |
| 2020 | 24.5× | 15.9× | 48.3× |
| 2019 | 47.0× | 15.7× | 60.0× |
| 2018 | 16.7× | 13.5× | 20.6× |
| 2017 | 15.5× | 14.4× | 17.2× |
| 2016 | 14.2× | 8.4× | 15.1× |
| 2015 | 9.1× | 8.0× | 12.1× |
| 2014 | 12.1× | 11.3× | 15.7× |
| 2013 | 12.1× | 11.1× | 21.4× |
| 2012 | 19.8× | 18.7× | 45.3× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Enovis CORP's size, closest first, today.
| Company | EV/EBIT |
|---|---|
| ENOVEnovis CORP | 191× |
| BVSBioventus | 26.2× |
| CDRECadre | 23.2× |
| STAAStaar Surgical | 57.7× |
| IRMDIradimed | 37.7× |
| EYENational Vision | 19.2× |
| LMATLemaitre Vascular | 22.6× |
| INSPInspire Medical Systems | 32.6× |
| MOVMovado | 11.8× |
| UFPTUFP Technologies | 24.9× |
| MDXGMimedx | 51.6× |
| Peer median | 25.5× |
Where Enovis CORP ranks
What the EV/EBIT tells you
What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.
Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.
More on Enovis CORP
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.